A272 UTILIZING BEDSIDE ULTRASOUND TO ASSESS MUSCLE MASS IN CIRRHOTIC PATIENTS ASSESSED FOR LIVER TRANSPLANTATION

摘要

Background: BackgroundMuscle atrophy is present in 40% of cirrhotic patients and associated with increased morbidity and mortality in those awaiting liver transplantation (LT). There is a two-fold increase in mortality, compared to non-sarcopenic patients, independent of liver dysfunction using Model for End-Stage Liver Disease (MELD). The current Sodium MELD score does not incorporate markers of nutritional status, or muscle loss. Ultrasound is a non-invasive method to evaluate skeletal muscle and is validated and emerging as a prognostic indicator of muscle atrophy, thereby improving detection of malnutrition.